Cavadino A

School of Population Health, Faculty of Medical and Health Sciences, University of Auckland, 22 Park Avenue, Grafton, Auckland, 1023, New Zealand.

4 papers · ORCID

ArticleLSD

LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.

Daldegan-Bueno D, Donegan CJ, Forsyth A +16

Europe PMC2024
ArticleLSD

PAM trial protocol: a randomised feasibility study of psychedelic microdosing-assisted meaning-centred psychotherapy in advanced stage cancer patients.

Wells A, Muthukumaraswamy APS, Morunga E +10

Europe PMC2024
ArticleLSD

An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).

Donegan CJ, Daldegan-Bueno D, Sumner R +15

Europe PMC2023
ArticleLSD

Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial.

Murphy RJ, Sumner R, Evans W +10

Europe PMC2023